Department of Internal Medicine
Hematology, Oncology and Blood & Marrow Transplantation Faculty
Gerald H. Clamon, M.D.
Dr. Clamon's clinical and research interests focus on studies of experimental therapeutics for advanced cancer. His clinical care is directed at the treatment, palliation, and support of patients with advanced cancer.
Honors, Awards, and Organizations
- Phi Beta Kappa
- Alpha Omega Alpha
- American Association for Cancer Research
- Diplomate, American Board of Internal Medicine and Board of Medical Oncology, and Board of Hematology
- American Society of Clinical Oncology
- International Association for the Study of Lung Cancer
- Principle Investigator, UI Membership in CALGB
- Reviewer, Chest, 1982-present
- Reviewer, Cancer, 1998-present
- Reviewer, Journal of Clinical Oncology, 1999-present
- Membership Committee, CALGB, 1986-present
- DATA Audit Committee, CALGB, 1992-97
- Chair, Clinical Cancer Center Protocol Review Committee, 1996-97
- Roc ha Lima, C.P.A., Herndon II, J. E., Ko sty, M., Clam on, G., Green, M. R.: Therapy Choices Among Older Patients with Lung Cancer: An Evaluation of Two Trials of the Cancer and Leukemia Group B. Cancer 94(Volume 1): 181-187, 2002.
- Nell, H. B, Perry, M. C., Clam on, G., Crawford, J., Miller, A. A., Herndon II, J., and Green, M. r. Carbonating/Topside/Palliate in the Treatment of Patients with Extensive Small-Cell Lung Cancer. Clinical Lung Cancer,
2 (No 3):204-209, 2001.
- Clam on, G., Herndon, J., Green, M., and Kelley, W.: Subcutaneous Interleukin-2 as Initial Therapy for Patients with Extensive Small Cell Lung Cancer. A Phase II Trial of Cancer and Leukemia Group B. Lung Cancer, 19 :25-29, 1998.